F2G’s attempt to end a two-decade drought in novel therapies for invasive fungal infections has hit a hurdle after the FDA said it was unable to approve its olorofim candidate. The US regulator sent a ...

UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which was turned down last year by the FDA. The Manchester-based company said the ...

First, uninstall Corsair iCUE from your computer via your system Settings or the Control Panel. The following steps will help you with that: After uninstalling the Corsair iCUE software, the next step ...

(MENAFN- GlobeNewsWire - Nasdaq) Data reinforce olorofim's potential as a first-in-class treatment for patients with invasive fungal diseases and limited or no antifungal treatment options MANCHESTER, ...

Data reinforce olorofim's potential as a first-in-class treatment for patients with invasive fungal diseases and limited or no antifungal treatment options MANCHESTER, United Kingdom, June 18, 2025 ...

HIGHS Interior luxury abounds, cosseting ride, distinguished styling. LOWS Uninspired handling, hands-free driving feature comes with a monthly charge, Reserve model approaches BMW pricing. VERDICT ...

DESPITE HIS HUMBLE BEGINNINGS as the penniless son of Czech immigrants, my father, Walter Soplata, amassed an extraordinary collection of warbirds. He grew up fascinated by airplanes during the Great ...

Sept 12 (Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop ...

MANCHESTER, United Kingdom, Sept. 12, 2024 (GLOBE NEWSWIRE) -- F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. U.K.-based biotechnology company F2G has raised $100 ...